Shannon Jackson

Contact Information
Providence Health Care, St. Paul’s Hospital
Department of Hematology
#450, 1144 Burrard Street
Vancouver, BC, Canada, V6Z 2A5
Tel 1-604-684-5794
Fax 1-604-684-5705
Dr.Jackson@providencehematology.com

Current Positions

  • Clinical Assistant Professor, Hematology/Bone Marrow Transplant, Medicine
  • Staff Hematologist, Providence Health Care

Research Interests

Inherited bleeding disorders including hemophilia, von Willebrand disease, rare coagulation factor deficiencies and hereditary platelet function disorders illustrate the consequence of both known and unknown genetic mutations in various coagulation proteins and platelet biological mechanisms. Medical care for these disorders is specialized and multidisciplinary. In British Columbia, I have had the opportunity to recently join the Provincial Adult Hemophilia and Bleeding Disorders Comprehensive Care program at St. Paul’s Hospital. I am interested in providing optimal clinical care to this unique group of patients and pursuing both clinical and translational research to 1) further our understanding of the coagulation system, especially in bleeding disorders that are less well defined, 2) improve the treatments available to those with bleeding disorders, 3) appreciate how aging impacts those with inherited bleeding disorders such as hemophilia.

Publication

  1. Vanden Hoek AL, Talbot K, Carter IS, Vickars L, Carter CJ, Jackson SC, Macgillivray RT, Pryzdial EL. Coagulation factor X Arg386 specifically affects activation by the intrinsic pathway: a novel patient mutation. J Thromb Haemost. 2012 Dec;10(12):2613-5.
  2. Jackson SC, Odiaman L, Card RT, van der Bom JG, Poon MC. Suspected collagen disorders in the bleeding disorder clinic: A case-control study. Haemophilia. 2012 Oct 3.
  3. Schneider-MacRae N, Jackson SC, Valentine KA, Lockyer J, Poon MC. A study of thrombophilia testing and counseling practices of family physicians using the script concordance method in Calgary, Canada. Clin Appl Thromb Hemost. 2012 Jul;18(4):403-8.
  4. Poon MC, Rand ML, Jackson SC. 2B or not to be–the 45-year saga of the Montreal Platelet Syndrome. Thromb Haemost. 2010 Nov 3;104(5):903-10.
  5. Skeith L, Jackson SC, Brooks J, Poon MC. Assessing baseline joint hypermobility as a risk factor for arthropathy development in moderate and severe haemophilia. Haemophilia. 2010 Jul 1;16(4):698-700.
  6. Fieldwalker MA, Jackson SC, Seal D. High transoxygenator pressure gradient in a patient with polycythemia vera. J Cardiothorac Vasc Anesth. 2010 Feb;24(1):104-8.
  7. Jackson SC, Sinclair GD, Cloutier S, Duan Z, Rand ML, Poon MC. The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation. Blood. 2009 Apr 2;113(14):3348-51.
  8. Jackson SC, Beck P, Buret AG, O’Connor PM, Meddings J, Pineo G, Poon MC. Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura. Int J Hematol. 2008 Sep;88(2):212-8.

Education

  • Bayer International Hemophilia Scholarship/Hemostasis Fellowship, University of Calgary, 2009
  • Hematology Residency, University of Calgary, 2007
  • MD, University of Calgary, 2001

Comments are closed, but trackbacks and pingbacks are open.